How to Mediate Cardioprotection in Ischemic Hearts—Accumulated Evidence of Basic Research Should Translate to Clinical Medicine

Author： Kitakaze Masafumi  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.24, Iss.3, 2010-06, pp. : 217-223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sublytic complement attack reduces infarct size in rabbit isolated hearts: evidence for C5a-mediated cardioprotection

By Tanhehco E.J.   Lee H.   Lucchesi B.R.  

Immunopharmacology, Vol. 49, Iss. 3, 2000-09 ,pp. : 391-399

Elsevier

Access to resources Recommend Favorite

Mechanism of Cardioprotection by Early Ischemic Preconditioning

By Yang Xiulan   Cohen Michael   Downey James  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 3, 2010-06 ,pp. : 225-234

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Trials and Evidence-Based Medicine

By  

Heart Drug, Vol. 2, Iss. 6, 2003-04 ,pp. : 269-272

Karger

Access to resources Recommend Favorite

How should the clinical efficiency of oocyte cryopreservation be measured?

By Edgar David H   Gook Debra A  

Reproductive BioMedicine Online, Vol. 14, Iss. 4, 2007-04 ,pp. : 430-435

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Cardioprotection in the Clinical Setting

By Ivanes Fabrice   Mewton Nathan   Rioufol Gilles   Piot Christophe   Elbaz Meyer   Revel Didier   Croisille Pierre   Ovize Michel  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 3, 2010-06 ,pp. : 281-287

Springer Publishing Company

Access to resources Recommend Favorite